Marc Benioff Says Wall Street's Fears That AI Will Kill Salesforce Are "Dead Wrong," Even as CRM Stock Has Fallen Over 25% in 2026. Should Investors Bet on His Conviction?

Salesforce’s fiscal Q1 revenue rose 13% YoY to a record $11.1B, prompting an FY revenue outlook raise to $45.9B–$46.2B (vs. $41.5B prior year). Agentforce usage hit 1.6B times in Q1, enabling Salesforce to handle double the customer inquiries as human agents, while EPS grew 52% YoY to $2.42. Despite a “SaaSpocalypse” sell-off, valuation is framed as improving (forward P/E ~14) and Citigroup lifted its target to $204 from $187, suggesting the stock may be oversold.

Analysis

The market is treating CRM as if AI is an exogenous substitute, but the more relevant mechanism is that AI gets embedded inside the workflow layer that already owns customer data and distribution. That usually strengthens switching costs first and only pressures revenue later if pricing fails to adapt. In the near term, the real winners are CRM’s own margins and product attach; the cleaner losers are lower-moat workflow vendors and SMB-oriented software names like HUBS, where AI can be adopted faster by customers and bundled away from standalone licenses.

The main distinction investors are missing is usage versus monetization. High agent activity can support retention and lower support costs without proving incremental ARR, so the upside case depends on conversion into premium tiers, usage-based fees, or broader module adoption. The next 1-3 month catalyst is not the narrative, but whether cRPO, net retention, and full-year guidance stay in the low-to-mid teens; if they do, the multiple can normalize, but if growth slips, the cheap forward P/E is just a value trap.

Contrarian view: the selloff likely over-discounted revenue destruction and under-discounted operating leverage. AI can compress service costs faster than it compresses software spend, which should help CRM’s margins before it becomes a revenue headwind. What would falsify the thesis over 6-18 months is evidence that Agentforce is merely a free retention feature, renewal rates soften, or enterprise customers reduce seat counts and module breadth rather than expanding them.

Key Decisions for Investors

• Buy CRM on staged weakness over the next 1-2 weeks rather than chasing strength; target a 15-20% upside re-rating if the market revises the forward multiple toward the high-teens, and cut risk if CRM re-breaks the June low area or if the next update shows cRPO deceleration.
• Pair trade: long CRM / short HUBS into the next two earnings cycles. Thesis: CRM has the stronger enterprise data moat and AI attach opportunity, while HUBS is more exposed to SMB price compression and faster AI substitution. Use the spread as a relative-value expression, not a directional software bet.
• If you want defined downside, use a 6-9 month CRM call spread instead of common stock to capture a post-selloff mean reversion. Structure around roughly 10% OTM / 25% OTM strikes from current spot; invalidate on a guide cut or weaker renewal metrics.
• Watch the next earnings print for monetization signals, not usage counts. If agent adoption stays high but no improvement shows up in net retention, upsell, or margin, reduce the long because the AI story will have been priced as a retention narrative rather than a revenue catalyst.